Tanager Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.31M Buy
1,128
+518
+85% +$611K 0.11% 56
2026
Q2
$732K Buy
610
+51
+9% +$52.1K 0.06% 75
2026
Q1
$514K Buy
559
+164
+42% +$166K 0.05% 81
2025
Q4
$424K Buy
395
+10
+3% +$9.6K 0.04% 89
2025
Q3
$294K Buy
385
+105
+38% +$78.1K 0.03% 102
2025
Q2
$218K Sell
280
-34
-11% -$26.4K 0.03% 112
2025
Q1
$259K Buy
+314
New +$261K 0.03% 101

Other funds holding LLY

Tanager Wealth Management's LLY Position: Q3 2026 in Review

Tanager Wealth Management increased its Eli Lilly (LLY) stake by 85% in Q3 2026, buying an estimated $611K and bringing the position to 1,128 shares worth $1.31M. The position accounts for 0.11% of the portfolio, ranked #56.

Tanager Wealth Management first reported a position in LLY in Q1 2025 and has held it in 7 quarters since. 3,244 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Tanager Wealth Management held 1,128 shares of Eli Lilly worth $1.31M as of Q3 2026.
  • Tanager Wealth Management bought 518 Eli Lilly shares in Q3 2026, an estimated $611K.
  • Eli Lilly made up 0.11% of Tanager Wealth Management's portfolio in Q3 2026, its #56 holding.
  • Tanager Wealth Management first reported a position in Eli Lilly in Q1 2025 and has held it in 7 quarters since.
  • 3,244 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Tanager Wealth Management's 13F filing for Q3 2026, filed 19 Oct 2026.